MedTech Daily Briefing
2026-06-02
|
Section 1: MedTech Industry News
Intuitive elevates Taylor Patton to chief commercial and marketing officer
MedTech Dive • June 01, 2026
|
Court overturns Insulet’s $59M trade secret verdict against EOFlow
MedTech Dive • June 01, 2026
|
Engineered Medical Seals for Critical Healthcare Applications - MassDevice
MassDevice • June 01, 2026
|
Teleflex announces $500M private notes offering - MassDevice
MassDevice • June 01, 2026
|
MicroPort launches portable ECG solution in Europe, Australia - MassDevice
MassDevice • June 01, 2026
|
Picard Medical’s SynCardia completes milestone study of next-gen total artificial heart - MassDevice
MassDevice • June 02, 2026
|
MIT, Apollon say needle-free CGM matched accuracy of leading sensors in study - MassDevice
MassDevice • June 02, 2026
|
Resmed completes $340M acquisition of Noctrix Health - MassDevice
MassDevice • June 02, 2026
|
Smith+Nephew launches next-gen Leaf patient monitoring platform - MassDevice
MassDevice • June 02, 2026
|
ShiraTronics completes enrollment in study of neuromod for chronic migraine - MassDevice
MassDevice • June 02, 2026
|
Petal Surgical adds more funding for incisionless surgical robot - MassDevice
MassDevice • June 02, 2026
|
Philips, Disney partner to improve MRI experience for children - MassDevice
MassDevice • June 01, 2026
|
MindMaze Therapeutics culls program, ends legacy ops from Relief merger to cut costs
Fierce Biotech • June 02, 2026
|
ASCO: Celcuity dares to dream of becoming $10B company after breast cancer win over Piqray
Fierce Biotech • June 01, 2026
|
ASCO: Bristol Myers’ $800M bispecific ADC aces China breast cancer study, putting TROP2 drugs on notice
Fierce Biotech • June 01, 2026
|
Abivax stock suffers as cancer cases overshadow stellar efficacy in ulcerative colitis phase 3 trial
Fierce Biotech • June 02, 2026
|
Praxis pauses one of its seizure programs after phase 2 fail
Fierce Biotech • June 02, 2026
|
ASCO: Takeda touts ‘tremendous potential’ of Innovent’s PD-1/IL-2 bispecific after seeing survival data
Fierce Biotech • June 01, 2026
|
At ASCO 2026, a ‘paradigm shift’ for a rare gut cancer looms
Fierce Biotech • June 01, 2026
|
ASCO, Ryght AI team up for breast cancer trial site selection
Fierce Biotech • June 01, 2026
|
Agios signs $165M deal for blood disorder drug from Korea’s Oscotec that flunked phase 2 study
Fierce Biotech • June 01, 2026
|
Rallybio swerves past Candid pothole to land deal with cancer drug developer Avenzo
Fierce Biotech • June 01, 2026
|
|
Section 2: National News — MedTech Relevant
| No relevant national MedTech headlines today. |
|
Section 3: VC Press Releases
|
Section 4: Public Market Roundup — as of June 01, 2026
|
▲ Top Gainers
| TNDM |
Tandem Diabetes Care |
+11.16% |
| PRCT |
Procept |
+5.81% |
| BBNX |
Beta Bionics |
+5.61% |
|
|
▼ Top Losers
| INGN |
Inogen |
-6.16% |
| AORT |
Artivion |
-5.14% |
| KMTS |
Kestra |
-5.03% |
|
📅 Upcoming Earnings (Next 7 Days)
| MDT |
Medtronic |
June 03, 2026 |
|
|
MedTech Daily Briefing • Curated by automation
|
|